Purpose
|
A muscarinic antagonist that has effects in both the central and peripheral nervous systems. It has been used in the treatment of arteriosclerotic, idiopathic, and postencephalitic parkinsonism. It has also been used to alleviate extrapyramidal symptoms induced by phenothiazine derivatives and reserpine.
|
Characteristics
|
Tradename: AKINETON Source of Compound: synthetic Target: AChR antagonist Receptor: Muscarinic AChR Status: USP, INN, BAN, JAN
|
Purification
|
All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
|
Purity
|
90?%
|
Formula
|
C21H29NO
|
Solubility
|
Water: 25.1 mg/L
|